PCMA Partners with Groups on Letter Urging Congress to Advance Legislation to Stop Drug Patent Abuse

The Pharmaceutical Care Management Association (PCMA) joined nearly 20 other organizations that support patients and affordable health care to call on Congress to speed generic and biosimilar market entry by ending Big Pharma’s use of patent thickets and protecting the use of skinny labels.     In a letter sent to leaders of the House Judiciary Committee and the Subcommittee on Courts, Intellectual Property, AI, and the Internet, PCMA and others expressed strong […]